Clinical Trials Directory

Trials / Completed

CompletedNCT00540098

Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder

A Randomized, Controlled Trial on the Effects of Paroxetine Versus Placebo in Combination With Aerobic Exercise or Relaxation Training in the Treatment of Panic Disorder

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
75 (actual)
Sponsor
University of Göttingen · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Efficacy and safety of a 10-weeks treatment protocol of paroxetine vs. placebo in combination with regular aerobic exercise (running) or regular relaxation training in the treatment of panic disorder.

Detailed description

In continuation of prior work from our group (Broocks A, Bandelow B, Pekrun G, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998; 155(5):603-9.) it is the purpose of this trial to test the assumed superiority of a combined therapy of paroxetine and aerobic exercise compared to placebo or unspecific relaxation training in panic disorder. Participants were randomized to a 10 week treatment protocol of paroxetine 40 mg daily or placebo in combination with regular exercise or regular relaxation after having given informed consent and screening of in- and exclusion criteria.

Conditions

Interventions

TypeNameDescription
DRUGparoxetine + aerobic exerciseparoxetine, 40 mg once daily + regular aerobic exercise
DRUGParoxetine + relaxationparoxetine, 40 mg once daily + regular relaxation training
DRUGPlacebo + aerobic exerciseplacebo pill once daily + regular aerobic exercise
DRUGPlacebo + relaxationplacebo pill once daily + regular relaxation training

Timeline

Start date
2001-09-01
Completion
2005-06-01
First posted
2007-10-05
Last updated
2007-10-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00540098. Inclusion in this directory is not an endorsement.